Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Cancer Genes

Genetic weakness points to potential drug target

US scientists have identified a molecule that, if targeted with drugs, could help slow the growth of tumour cells carrying certain genetic faults.

Researchers discover genetic fingerprint of HPV virus in some head and neck cancers

A large US study has pinpointed genetic errors that mark out head and neck cancers caused by the human papillomavirus (HPV).

Gene linked to aggressive breast cancer

UK scientists have linked an overactive gene to an aggressive type of breast cancer.

The Enemy Within – 50 years of fighting cancer

Cancer has always been with us, affecting our species for many thousands of years. For most of that time there was little we could do in the face of such a powerful...

The shape of all things – the year of crystallography

This entry is part 20 of 20 in the series Our milestones

Crystals have been a source of fascination for thousands of years, and for good reason. Not only are they...

Combining images and genetic data proves gene loss behind aggressive ovarian cancers

Scientists have shown that loss of a gene called PTEN  triggers some cases of an aggressive form of ovarian cancer.

UK Government missing the target over new cancer drug tests

Many of the new generation of cancer drugs are designed to target specific genetic mutations in a patient’s cancer – these are often known as ‘targeted’ medicines.


Drug target discovered for aggressive childhood brain tumour

US scientists have successfully used an experimental drug to treat mice with an aggressive form of childhood brain cancer.

Getting cancer’s story straight

In this guest post, Andrew Hudson, one of our clinical fellows from Dr John Brognard’s laboratory at the Cancer Research UK Manchester Institute, at The University of...

Coming ever closer – first PARP inhibitor on track to be licensed in Europe

Regular readers of this blog may recognise the term ‘PARP inhibitor’. We first wrote about these exciting new drugs back in 2008 and have mentioned them regularly ever...